Generalizability and reach of a randomized controlled trial to improve oral health among home care recipients: comparing participants and nonparticipants at baseline and during follow-up.
Claims data
Generalizability
Geriatric dentistry
Home care
Long-term care
Non-response
Oral health
Randomized controlled trial
Reach
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
08 Jul 2022
08 Jul 2022
Historique:
received:
21
01
2022
accepted:
09
06
2022
entrez:
8
7
2022
pubmed:
9
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
The generalizability of randomized controlled trials (RCTs) with a low response can be limited by systematic differences between participants and nonparticipants. This participation bias, however, is rarely investigated because data on nonparticipants is usually not available. The purpose of this article is to compare all participants and nonparticipants of a RCT to improve oral health among home care recipients at baseline and during follow-up using claims data. Seven German statutory health and long-term care insurance funds invited 9656 home care recipients to participate in the RCT MundPflege. Claims data for all participants (n = 527, 5.5% response) and nonparticipants (n = 9129) were analyzed. Associations between trial participation and sex, age, care dependency, number of Elixhauser diseases, and dementia, as well as nursing, medical, and dental care utilization at baseline, were investigated using multivariable logistic regression. Associations between trial participation and the probability of (a) moving into a nursing home, (b) being hospitalized, and (c) death during 1 year of follow-up were examined via Cox proportional hazards regressions, controlling for baseline variables. At baseline, trial participation was positively associated with male sex (odds ratio 1.29 [95% confidence interval 1.08-1.54]), high (vs. low 1.46 [1.15-1.86]) care dependency, receiving occasional in-kind benefits to relieve caring relatives (1.45 [1.15-1.84]), having a referral by a general practitioner to a medical specialist (1.62 [1.21-2.18]), and dental care utilization (2.02 [1.67-2.45]). It was negatively associated with being 75-84 (vs. < 60 0.67 [0.50-0.90]) and 85 + (0.50 [0.37-0.69]) years old. For morbidity, hospitalizations, and formal, respite, short-term, and day or night care, no associations were found. During follow-up, participants were less likely to move into a nursing home than nonparticipants (hazard ratio 0.50 [0.32-0.79]). For hospitalizations and mortality, no associations were found. For half of the comparisons, differences between participants and nonparticipants were observed. The RCT's generalizability is limited, but to a smaller extent than one would expect because of the low response. Routine data provide a valuable source for investigating potential differences between trial participants and nonparticipants, which might be used by future RCTs to evaluate the generalizability of their findings. German Clinical Trials Register DRKS00013517 . Retrospectively registered on June 11, 2018.
Sections du résumé
BACKGROUND
BACKGROUND
The generalizability of randomized controlled trials (RCTs) with a low response can be limited by systematic differences between participants and nonparticipants. This participation bias, however, is rarely investigated because data on nonparticipants is usually not available. The purpose of this article is to compare all participants and nonparticipants of a RCT to improve oral health among home care recipients at baseline and during follow-up using claims data.
METHODS
METHODS
Seven German statutory health and long-term care insurance funds invited 9656 home care recipients to participate in the RCT MundPflege. Claims data for all participants (n = 527, 5.5% response) and nonparticipants (n = 9129) were analyzed. Associations between trial participation and sex, age, care dependency, number of Elixhauser diseases, and dementia, as well as nursing, medical, and dental care utilization at baseline, were investigated using multivariable logistic regression. Associations between trial participation and the probability of (a) moving into a nursing home, (b) being hospitalized, and (c) death during 1 year of follow-up were examined via Cox proportional hazards regressions, controlling for baseline variables.
RESULTS
RESULTS
At baseline, trial participation was positively associated with male sex (odds ratio 1.29 [95% confidence interval 1.08-1.54]), high (vs. low 1.46 [1.15-1.86]) care dependency, receiving occasional in-kind benefits to relieve caring relatives (1.45 [1.15-1.84]), having a referral by a general practitioner to a medical specialist (1.62 [1.21-2.18]), and dental care utilization (2.02 [1.67-2.45]). It was negatively associated with being 75-84 (vs. < 60 0.67 [0.50-0.90]) and 85 + (0.50 [0.37-0.69]) years old. For morbidity, hospitalizations, and formal, respite, short-term, and day or night care, no associations were found. During follow-up, participants were less likely to move into a nursing home than nonparticipants (hazard ratio 0.50 [0.32-0.79]). For hospitalizations and mortality, no associations were found.
CONCLUSIONS
CONCLUSIONS
For half of the comparisons, differences between participants and nonparticipants were observed. The RCT's generalizability is limited, but to a smaller extent than one would expect because of the low response. Routine data provide a valuable source for investigating potential differences between trial participants and nonparticipants, which might be used by future RCTs to evaluate the generalizability of their findings.
TRIAL REGISTRATION
BACKGROUND
German Clinical Trials Register DRKS00013517 . Retrospectively registered on June 11, 2018.
Identifiants
pubmed: 35804423
doi: 10.1186/s13063-022-06470-y
pii: 10.1186/s13063-022-06470-y
pmc: PMC9264743
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
560Subventions
Organisme : Innovation Committee of the Federal Joint Committee
ID : 01NVF17003
Informations de copyright
© 2022. The Author(s).
Références
Trials. 2015 Mar 11;16:88
pubmed: 25873096
Lung Cancer. 2011 Sep;73(3):325-31
pubmed: 21324544
Contemp Clin Trials Commun. 2021 Aug 03;23:100829
pubmed: 34401599
Eur Urol. 2017 Nov;72(5):789-798
pubmed: 28578829
J Clin Epidemiol. 2022 Jan;141:175-186
pubmed: 34525408
Z Evid Fortbild Qual Gesundhwes. 2011;105(10):751-61
pubmed: 22176984
Aging Clin Exp Res. 2014 Oct;26(5):555-9
pubmed: 24647931
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Trials. 2021 May 10;22(1):340
pubmed: 33971933
J Clin Epidemiol. 2022 Jan;141:187-197
pubmed: 34520851
Br J Cancer. 2013 Apr 16;108(7):1402-7
pubmed: 23511558
Contemp Clin Trials Commun. 2016 Mar 02;3:23-31
pubmed: 29736453
BMC Public Health. 2018 Sep 4;18(1):1092
pubmed: 30180833
J Clin Epidemiol. 2016 Aug;76:166-74
pubmed: 26898705
Prev Med Rep. 2020 Apr 08;19:101092
pubmed: 32461878
Scand J Public Health. 2007;35(4):410-7
pubmed: 17786805
Eur J Public Health. 2021 Oct 26;31(5):991-996
pubmed: 33970254
Lancet. 2005 Jan 1-7;365(9453):82-93
pubmed: 15639683
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
BMJ. 2021 Mar 3;372:n450
pubmed: 33658187
BMC Oral Health. 2019 May 28;19(1):91
pubmed: 31138273
Trials. 2018 Jan 11;19(1):29
pubmed: 29325575
Int J Environ Res Public Health. 2021 Sep 03;18(17):
pubmed: 34501925
Trials. 2013 Apr 30;14:116
pubmed: 23782890
Br J Gen Pract. 2012 May;62(598):e371-7
pubmed: 22546597
BMJ Open. 2017 Aug 1;7(7):e016216
pubmed: 28765131
JAMA Netw Open. 2018 Dec 7;1(8):e186019
pubmed: 30646311
Int J Cardiol. 2019 Aug 15;289:1-5
pubmed: 31078351
Trials. 2016 Oct 12;17(1):494
pubmed: 27733181
Trials. 2016 Apr 01;17:178
pubmed: 27039181
PLoS Med. 2010 Nov 09;7(11):e1000368
pubmed: 21085696
Gesundheitswesen. 2012 May;74(5):291-7
pubmed: 21755492
J Clin Epidemiol. 2022 Jan;141:172-174
pubmed: 34525407
BMJ. 2021 Apr 29;373:n857
pubmed: 33926904
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Gesundheitswesen. 2017 Jan;79(1):e1-e9
pubmed: 26492391
Ger Med Sci. 2015 Oct 14;13:Doc17
pubmed: 26512232
J Am Geriatr Soc. 2009 Oct;57(10):1844-9
pubmed: 19682128
Australas J Ageing. 2016 Dec;35(4):273-280
pubmed: 27226074
BMC Med. 2020 Jan 20;18(1):6
pubmed: 31955710
JAMA Netw Open. 2021 Apr 1;4(4):e214732
pubmed: 33825838
Clin Trials. 2006;3(5):431-42
pubmed: 17060217
Pilot Feasibility Stud. 2015 Apr 14;1:15
pubmed: 27965794
Trials. 2020 Mar 12;21(1):259
pubmed: 32164790
BMJ. 2000 Sep 16;321(7262):694-6
pubmed: 10987780
J Clin Epidemiol. 2022 Jan;141:198-209
pubmed: 34525409
Trials. 2006 Apr 07;7:9
pubmed: 16603070
Cochrane Database Syst Rev. 2018 Feb 22;2:MR000013
pubmed: 29468635
Trials. 2013 Jun 09;14:166
pubmed: 23758961
Health Syst Transit. 2020 Dec;22(6):1-272
pubmed: 34232120
BMC Public Health. 2018 Jan 23;18(1):170
pubmed: 29361929
J Clin Epidemiol. 1999 Dec;52(12):1143-56
pubmed: 10580777
BMJ. 2008 May 3;336(7651):995-8
pubmed: 18456631